Skip to main content
SpringerLink
Log in

New strategies for BMT and organ transplantation

  • Recent Advances in Hematopoietic Stem Cell Transplantation
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Bone marrow transplantation (BMT) is now one of the most powerful strategies for the treatment of hematologic disorders (leukemia, aplastic anemia, etc), congenital immunodeficiencies, metabolic disorders, and also autoimmune diseases. Using various autoimmune-prone mice, we have previously shown that conventional allogeneic (allo) BMT can be used to treat a range of autoimmune diseases. We have very recently established new strategies for BMT and organ grafts. For BMT, to minimize the contamination of BMCs with T cells from the peripheral blood, we developed, using cynomolgus monkeys, a “Perfusion Method” to replace the conventional aspiration method for collecting bone marrow cells (BMCs). We injected the BMCs collected this way directly into the bone marrow cavity of recipients that had received fractionated irradiation (intra-bone marrow [IBM] injection). This “IBM-BMT” was found to be effective in treating autoimmune diseases in radiation-sensitive and chimeric-resistant MRL/Ipr mice. In addition, this strategy was found to be applicable for the transplantation of organs, such as the skin and pancreas islets in mice and rats. We believe that these strategies for BMT and organ transplantation herald a new era in transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ikehara S, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases.Proc Natl Acad Sci USA. 1985;82:2483–2487.

    Article  PubMed  CAS  Google Scholar 

  2. Ikehara S, Ohtsuki H, Good RA, et al. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation.Proc Natl Acad Sci USA 1985;82:7743–7747.

    Article  PubMed  CAS  Google Scholar 

  3. Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation.Exp Hematol 2001;29:661–669.

    Article  PubMed  CAS  Google Scholar 

  4. Baldwin JL, Strob R, Thomas ED, Mannik M. Bone marrow transplantation in patients with gold-induced marrow aplasia.Arthritis Rheum. 1977;20:1043–1048.

    Article  PubMed  CAS  Google Scholar 

  5. Marmont AM. Immune ablation followed by allogeneic or autologous bone marrow transplantation. A new treatment for severe autoimmune diseases?Stem Cells. 1994;12:125–135.

    Article  PubMed  CAS  Google Scholar 

  6. Burt PK. BMT for severe autoimmune diseases: An idea whose time has come.Oncology. 1997;11:1001–1024.

    PubMed  CAS  Google Scholar 

  7. Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation.Blood. 1996;88:3621–3625.

    PubMed  CAS  Google Scholar 

  8. Kushida T, Inaba M, Hisha H, et al. Intra-bone marrow injection of allogeneic bone marrow cells: A powerful new strategy for treatment of intractable autoimmune diseases in MRL/Ipr mice.Blood. 2001;97:3292–3299.

    Article  PubMed  CAS  Google Scholar 

  9. Ikehara S, Yasumizu R, Inaba M, et al. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.Proc Natl Acad Sci USA. 1989;86:3306–3310.

    Article  PubMed  CAS  Google Scholar 

  10. Hashimoto F, Sugiura K, Inoue K, Ikehara S. Histocompatibility complex restriction between hematopoietic stem cells.Blood. 1997;89:49–54.

    PubMed  CAS  Google Scholar 

  11. Sugiura K, Hisha H, Ishikawa J, et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro.Stem Cells. 2001;19:46–58.

    Article  PubMed  CAS  Google Scholar 

  12. Ikehara S, Inaba M, Ishida S, et al. Rationale for transplantation of both allogeneic bone marrow and stromal cells in thetreatment of autoimmune diseases. UCLA Symposia on Molecular and Cellular Biology RE, Champlin and RP Gale (Eds.) New Series, Wiley-Liss, Inc., New York Chichester Brisbane Toronto Singapore 1991;137:251–257.

    Google Scholar 

  13. Ishida T, Inaba M, Hisha H, et al. Requirement of donorderived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: complete prevention of recurrence of autoimmune diseases in MRL/MP Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.J Immunol. 1994;152:3119–3127.

    PubMed  CAS  Google Scholar 

  14. Zhang Y, Yasumizu R, Sugiura K, et al. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection.Eur J Immunol. 1994;24:1558–1565

    Article  PubMed  CAS  Google Scholar 

  15. Sugiura K, Hisha H, Ishikawa J, et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro.Stem Cells 2001;19:46–58.

    Article  PubMed  CAS  Google Scholar 

  16. Morita H, Sugiura K, Inaba M, et al. A strategy for organ allografts without using immunosuppressants and irradiation.Proc Natl Acad Sci USA. 1998;95:6947–6952.

    Article  PubMed  CAS  Google Scholar 

  17. Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation.Exp Hematol. 2001;29:661–669.

    Article  PubMed  CAS  Google Scholar 

  18. Kushida T, Inaba M, Takeuchi K, Sugiura K, Ogawa R, Ikehara S. Treatment of intractable autoimmune diseases in MRL/Ipr mice using a new strategy for allogeneic bone marrow transplantation.Blood. 2000;95:1862–1868.

    PubMed  CAS  Google Scholar 

  19. Takeuchi K, Inaba M, Miyashima S, Ogawa R, Ikehara S. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/Ipr mice.Blood. 1998;91:4616–4623.

    PubMed  CAS  Google Scholar 

  20. Kushida T, Inaba M, Hisha H, et al. Crucial role of donorderived stromal cells in successful treatment for intractable autoimmune diseases in MRL/Ipr mice by BMT via portal vein.Stem Cells 2001;19:226–235.

    Article  PubMed  CAS  Google Scholar 

  21. Fan T, Hisha H, Jin T, et al. Successful allogeneic bone marrow transplantation (BMT) by injection of bone marrow cells via portal vein: Stromal cells as BMT-facilitating cells.Stem Cells. 2001;19:144–150.

    Article  PubMed  CAS  Google Scholar 

  22. Nakamura T, Good RA, Inoue S, Maung Manug Oo, Hamashima Y, Ikehara S. Successful liver allografts in mice by combination with allogeneic bone marrow transplantation.Proc Natl Acad Sci USA. 1986;83:4529–4532.

    Article  PubMed  CAS  Google Scholar 

  23. Yasumizu R, Sugiura K, Iwai H, et al. Treatment of type I diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue.Proc Natl Acad Sci USA. 1987;84:6555–6557.

    Article  PubMed  CAS  Google Scholar 

  24. Jin T, Toki J, Inaba M, et al. Novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor bone marrow cells via portal vein.Transplantation. 2001;71:1725–1731.

    Article  PubMed  CAS  Google Scholar 

  25. Ikebukuro K, Adachi Y, Yamada Y, et al. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats.Transplantation. 2002;73:512–518.

    Article  PubMed  Google Scholar 

  26. Kushida T, Inaba M, Ikebukuro K, et al. A new method for bone marrow cell harvesting.Stem Cells. 2000;18:453–456.

    Article  PubMed  CAS  Google Scholar 

  27. Spivey WH. Intraosseous infusion.J Pediatr. 1987;111:639–643.

    Article  PubMed  CAS  Google Scholar 

  28. Hagglund H, Ringden O, Agren B, et al. Intraosseous compared to intractable infusion of allogeneic bone marrow.Bone Marrow Transplant. 1998;21:331–335.

    Article  PubMed  CAS  Google Scholar 

  29. Green MC, Sweet HO, Bunker LE. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton.Am J Pathol. 1976;82:493–512.

    PubMed  CAS  Google Scholar 

  30. Oyaizu H, Adachi Y, Takeuchi S, et al. Treatment of emphysema in Tsk mice by a new bone marrow transplantation method. Submitted.

  31. Ishioka N, Inaba M, Kushida T, et al. Prevention of senile osteoporosis in SAMP6 mice by intra-bone marrow injection of allogeneic bone marrow cells. Submitted.

Download references

Author information

Authors and Affiliations

  1. First Department of Pathology, Transplantation Center, Regeneration Research Center for Intractable Diseases, Kansai Medical University, Moriguchi City, Osaka, Japan

    Susumu Ikehara

Authors
  1. Susumu Ikehara
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Ikehara, S. New strategies for BMT and organ transplantation. Int J Hematol 76 (Suppl 1), 161–164 (2002). https://doi.org/10.1007/BF03165237

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03165237

Keywords

Search

Navigation